S, A., IA, G., A, S., R, S., JC, N., NO, K., . . . DW, L. (2025). The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer. Annals of surgical oncology, 32(10), 7326. https://doi.org/10.1245/s10434-025-17804-w
Chicago Style (17th ed.) CitationS, Aboelmaaty, Gomaa IA, Sileo A, Sassun R, Ng JC, Keshk NO, McKenna NP, Perry WR, and Larson DW. "The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer." Annals of Surgical Oncology 32, no. 10 (2025): 7326. https://doi.org/10.1245/s10434-025-17804-w.
MLA (9th ed.) CitationS, Aboelmaaty, et al. "The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer." Annals of Surgical Oncology, vol. 32, no. 10, 2025, p. 7326, https://doi.org/10.1245/s10434-025-17804-w.